Although currently tiny and narrowly focused on a handful of disease areas and countries, the biosimilar industry is set to expand as patents expire on top biologics, payers push for…
The post Top 5 Challenges Faced By Biosimilars appeared first …
For the last century, drug development consisted of tiny-molecule treatments focused at mass audience. It worked for some patients while it didn’t for the rest. In some cases, we knew…
The post Top 6 issues facing the biotechnology industry appea…
This article was originally published by Christopher Southan, Peter Varkonyi, Kiran Boppana, Sarma A.R.P. Jagarlapudi, and Sorel Muresan at PLoS ONE 8(10): e77142. Abstract The statistics of drug development output and…
The post Tracking 20 Years…
By: Pankaj Mondal, DrugPatentWatch Staff Writer When it comes to measuring the success of a new drug, the amount of time required to complete the entire approval process become a…
The post Accelerating Drug Approvals in the US appeared first on D…
Here’s a brief note in response to some of the discussions I’ve seen regarding the merit of patents. Many of the anti-patent arguments focus on things which probably never should have been patented. But few address the things which only exist because of patents. In some industries (e.g. software), patents are often seen as a […]
DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. PRELAY (troglitazone) Sankyo Patent number: 5,859,037 Expiration Date: Nov 13, 2017 PRELAY (troglitazone) Sankyo Patent number: 6,011,049 Expiration Date: Nov 13, 2017 STARLIX (nateglinide) Novartis Patent […]
Pharmaceutical competition incorporates different tactics in different markets because countries have divergent approaches to regulating healthcare costs. Both price and product have roles in defining the competitive landscape in pharmaceuticals,……
DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. VIOXX (rofecoxib) Merck Patent number: 6,063,811 Expiration Date: Nov 6, 2017 QUTENZA (capsaicin) Acorda Patent number: 6,239,180 Expiration Date: Nov 6, 2017 PREZISTA (darunavir ethanolate) Janssen […]
DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. NORMOCARB HF 25 (magnesium chloride; sodium bicarbonate; sodium chloride) Dialysis Sups Patent number: 5,945,449 Expiration Date: Oct 31, 2017 NORMOCARB HF 35 (magnesium chloride; sodium bicarbonate; […]
We live in a digital world. The way we interact has undergone a tremendous change in the last decade and this change is gradually reshaping our society itself. It’s difficult…
The post How can pharmaceutical companies play a key role in the digit…